|
PAPOLG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.669400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.397900E-02 |
| Normal-vs-Stage2 |
3.607200E-01 |
| Normal-vs-Stage3 |
9.159400E-01 |
| Normal-vs-Stage4 |
9.403400E-01 |
| Stage1-vs-Stage2 |
3.064100E-02 |
| Stage1-vs-Stage3 |
1.362000E-01 |
| Stage1-vs-Stage4 |
3.345200E-01 |
| Stage2-vs-Stage3 |
4.341200E-01 |
| Stage2-vs-Stage4 |
6.264400E-01 |
| Stage3-vs-Stage4 |
9.781800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.438830E-01 |
| Normal-vs-AfricanAmerican |
3.691600E-01 |
| Normal-vs-Asian |
6.561600E-01 |
| Caucasian-vs-AfricanAmerican |
8.256000E-01 |
| Caucasian-vs-Asian |
4.983800E-01 |
| AfricanAmerican-vs-Asian |
5.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.785900E-02 |
| Normal-vs-Female |
2.295000E-01 |
| Male-vs-Female |
4.178100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.015900E-02 |
| Normal-vs-Extreme_Weight |
1.585830E-02 |
| Normal-vs-Obese |
8.510600E-01 |
| Normal-vs-Extreme_Obese |
1.944840E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.621400E-01 |
| Normal_Weight-vs-Obese |
1.040410E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.603200E-01 |
| Extreme_Weight-vs-Obese |
2.604300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.236200E-01 |
| Obese-vs-Extreme_Obese |
3.741600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.239000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.025600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.103500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.403100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.573400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.669900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.320100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.197820E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.067800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.267800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.127500E-02 |
| Normal-VS-Type2 PRCC |
7.585700E-02 |
| Normal-VS-KIRP CIMP |
1.111730E-02 |
| Normal-VS-Unclassified PRCC |
5.056000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.247800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.799200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.146980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.386310E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.316100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.550200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.817800E-03 |
| Normal-vs-N1 |
2.355200E-01 |
| Normal-vs-N2 |
9.967600E-01 |
| N0-vs-N1 |
2.517700E-03 |
| N0-vs-N2 |
3.299200E-01 |
| N1-vs-N2 |
6.098200E-01 |
|
|
